Equinor ASA
EQNR | NYSE
$48.75
+$1.17 (+2.46%)
At close: Oct 30, 2026, 4:00 PM ET
$46.37
-$2.38 (-4.88%)
Pre-market:
Nov 2, 2026, 9:06 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 106.16B | 102.5B | 106.85B | 149B | 88.74B | 45.75B |
Cost of Revenue | 77.66B | 59.88B | 58.81B | 60.2B | 46.88B | 36.22B |
Gross Profit | 28.5B | 42.63B | 48.04B | 88.81B | 41.87B | 9.53B |
Operating Income | 27.28B | 30.93B | 35.77B | 78.81B | 33.66B | -3.42B |
Interest Income | 1.18B | 1.8B | 2.23B | 1.13B | 112M | 221M |
Pretax Income | 25.17B | 30.99B | 37.88B | 78.6B | 31.58B | -4.26B |
Net Income | 5.06B | 8.81B | 11.89B | 28.75B | 8.56B | -5.51B |
Selling & General & Admin | 1.21B | 1.26B | 1.22B | 986M | 780M | 706M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | 10.45B | 11.05B | 9.01B | 7.42B | 12.25B |
Operating Expenses | 1.21B | 11.7B | 12.27B | 10B | 8.2B | 12.96B |
Interest Expense | 1.44B | 1.06B | 1.12B | 929M | 769M | 980M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 78.87B | 71.58B | 71.08B | 70.19B | 55.08B | 49.18B |
Income Tax Expense | 20.09B | 22.16B | 25.98B | 49.86B | 23.01B | 1.24B |
Shares Outstanding (Basic) | 2.59B | 2.82B | 3.02B | 3.17B | 3.25B | 3.27B |
Shares Outstanding (Diluted) | 2.6B | 2.83B | 3.03B | 3.18B | 3.25B | 3.27B |
EPS (Basic) | 1.95 | 3.12 | 3.93 | 9.06 | 2.64 | -1.68 |
EPS (Diluted) | 1.95 | 3.11 | 3.93 | 9.03 | 2.63 | -1.68 |
EBITDA | 36.46B | 41.95B | 50.19B | 86.27B | 43.2B | 11.96B |
EBIT | 26.59B | 32.04B | 39.01B | 79.53B | 32.35B | -3.28B |
Depreciation & Amortization | 9.87B | 9.91B | 11.18B | 6.73B | 10.85B | 15.24B |
Add to Watchlist
Select watchlists to add or remove EQNR